# Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

> clinical trial · VERIFIED · 2026-07-01

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Metastatic Dedifferentiated Liposarcoma

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06422806

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.